Efficacy and Safety of SBRT Combined With Cardonilizumab and Lenvastinib in the Treatment of Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
Clinical trial NCT06040177 · UNKNOWN
Trial details
- NCT number
- NCT06040177
- Sponsor
- First Affiliated Hospital of Guangxi Medical University
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-02
- Primary completion
- 2023-02-02
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.